Quick Answer
Instil Bio, Inc. reported Diluted EPS of $10.70 per share (loss) for fiscal year 2025.
Instil Bio, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$10.70 | +6.1% |
| 2024 | -$11.39 | +52.5% |
| 2023 | -$24.00 | +30.4% |
| 2022 | -$34.46 | -2228.4% |
| 2021 | -$1.48 | +37.3% |
| 2020 | -$2.36 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.01 | +43.2% | +38.0% |
| June 30, 2025 | -$3.24 | -41.5% | +25.0% |
| March 31, 2025 | -$4.32 | -15.5% | -22.0% |
| September 30, 2024 | -$3.54 | +65.9% | -54.6% |
| June 30, 2024 | -$2.29 | +20.2% | +38.8% |
| March 31, 2024 | -$3.74 | +57.4% | +63.9% |
| September 30, 2023 | -$10.37 | -2311.6% | -261.3% |
| June 30, 2023 | -$2.87 | -523.9% | +67.3% |
- Instil Bio, Inc. showed an increase of +6.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, Instil Bio, Inc.’s diluted eps has declined by 353.4% (from $2.36 per share (loss) to $10.70 per share (loss)).
- The most recent figure is from Instil Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: